Volume : 09, Issue : 01, January – 2022

Title:

24.CARDIOVASCULAR DISEASE PREVENTION, OVERVIEW OF RISK FACTORS

Authors :

Hussain Saeed Aldhamen, Abdullah Salman Ali Bueid, Abdullah Ali Alshawaf, Ali Ahmed Albahrani, Nawi Jabr Alshammari, Anmar Essam Amin Koudwardia, Nabil Hamady Alshikh, Majdi Naif Albeshri, Amin Salem Alkhattabi, Badria Daffi Albeshri, Ameen Mousa Alhazmi, Meshal Mousa Alhazmi

Abstract :

Cardiovascular diseases (CVD) are a group of disorders of the heart and blood vessels which is the most significant cause of death globally. Despite the critical fatality rate 90% CVD can be prevented by taking necessary precautions. We conducted a search in literature to related topics concerning the prevention measures of CVD that are discussed in major electronic databases.
Health and wellbeing is one of the most primary and significant concerns for mankind. However this concern is constantly challenged by diseases and illnesses. While some of these diseases are fatal, some can be cured or their negative impacts could be minimized if diagnosed at early stages. The diseases that challenge the wellbeing of an organism can be categorized into two main categories based on the agent of the said disease. Early diagnosis plays a crucial role in secondary prevention. This requires intensive knowledge of risk factors contributing to CVD and different interactions among them. Some common risk factors of CVD include obesity, gender, age, blood lipids, and smoking. Since the invention of artificial intelligence CVD prediction has evolved into a new level, where machines are able to analyze millions of data sets and identify relations between different risk factors.

Cite This Article:

Please cite this article in press Hussain Saeed Aldhamen et al, Cardiovascular Disease Prevention, Overview Of Risk Factors ., Indo Am. J. P. Sci, 2022; 09(01).

Number of Downloads : 10

References:

1. WHO. Cardiovascular diseases (CVDs). 2016. Available at: http://www.who.int/mediacentre/factsheets/fs317/en/ (accessed 10 October 2016).
2. Lopez AD. Assessing the burden of mortality from cardiovascular diseases. World Health Star. Q. 1993;46:91–96.
3. Dodu SRA. Emergence of cardiovascular disease in developing countries. Cardiology. 1988;75:56–64.
4. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2010;122:e584–636.
5. Cohen R, Budoff M, McClelland RL, Sillau S, Burke G, Blaha M, et al. Significance of a positive family history for coronary heart disease in patients with a zero coronary artery calcium score (from the multi-ethnic study of atherosclerosis) Am J Cardiol. 2014;114:1210–4.
6. Goff DC, Jr, Lloyd-Jones DM, Bennett G, Coady S, D’Agostino RB, Gibbons R, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S49–73.
7. World Health Organization. Prevention of Recurrent Heart Attacks and Strokes in Low and Middle Income Populations. Evidence-Based Recommendations for Policy Makers and Health Professionals. Geneva: 2003. [Last accessed on 2017 Jul 25]. Available from: http://www.who.int/bookorders .
8. Institute of Medicine: Dietary reference intakes for energy, carbohydrates, fiber, fat, protein, and amino acids. Washington DC: The National Academies Press; 2002.
9. Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2016; 37: 2315–2381.
10. Eckel RH, Jakicic JM, Ard JD, et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013. 2014: 63(25_PA).
11. NICE. Cardiovascular disease: risk assessment and reduction, including lipid modification. NICE Guideline CG181, 2016.
12. Perk J, De Backer G, Gohlke H, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). Eur Heart J 2012; 33: 1635–1701.
13. de Souza RJ, Mente A, Maroleanu A, et al. Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies. BMJ 2015; 351: h3978–h3978.
14. Kottke TE, Battista RN, DeFriese GH, et al. Attributes of successful smoking cessation interventions in medical practice: a meta-analysis of 39 controlled trials. JAMA 1988; 259: 2882–2889.
15. Tzivoni D, Keren A, Meyler S, et al. Cardiovascular safety of transdermal nicotine patches in patients with coronary artery disease who try to quit smoking. Cardiovasc Drugs Ther 1998; 12: 239–244.
16. Bhatnagar A. E-Cigarettes and cardiovascular disease risk: evaluation of evidence, policy implications, and recommendations. Curr Cardiovasc Risk Rep 2016; 10: 1–10.
17. Khosravi A, Akhavan Tabib A, Golshadi I, et al. The relationship between weight and CVD risk factors in a sample population from central Iran (based on IHHP). ARYA Atheroscler 2012; 8: 82–89.
18. Leong DP, Smyth A, Teo KK, et al. Patterns of alcohol consumption and myocardial infarction risk: observations from 52 countries in the INTERHEART case-control study. Circulation 2014; 130: 390–398.
19. Holmes MV, Dale CE, Zuccolo L, et al. Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data. BMJ 2014; 349: g4164–g4164.
20. Garcia S. Alcohol Consumption and CVD: The case for moderation, 2015. Available at: http://www.acc.org/latest-in-cardiology/articles/2015/01/05/13/06/alcohol-consumption-and-cvd-the-case-for-moderation (accessed 25 October 2016).
21. Wilhelmsson C. Coronary heart disease: epidemiology of smoking and intervention studies of smoking. Am Heart J. 1988;115:242–249. Wilhelmsson C. Coronary heart disease: epidemiology of smoking and intervention studies of smoking. Am Heart J. 1988;115:242–249. Wilhelmsson C. Coronary heart disease: epidemiology of smoking and intervention studies of smoking. Am Heart J. 1988;115:242–249.
22. Rosenberg L, Kaufman D, Helmrich S, Shapiro S. The risk of myocardial infarction after quitting smoking in men under 55 years of age. N Eng J Med. 1985;313:1511–1514.
23. Law M. Plant sterol and sterol margarines and health. BMJ. 2000;329:861–864.
24. Turner RC, Millns H, Neil HA, Stratton IM, Manley SE, Matthews DR, Holman RR. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus. UKPDS. BMJ. 1998;316:823–828.
25. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbot R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765–774.